1VAN DEN BEUKEN-VAN EVERDINGEN M H, DE RIJKE J M, KESSELS A G, et al. Prevalence of pain in patients with cancer~ a systematic review of the past 40 years [J]. AnnOneol, 2007, 18(9): 1437-1449.
2HEARN J, HIGGINSON I J. Cancer pain epidemiology: a systematic review[M]//BRUERA E D, PORTENOY R K. Cancer Pain, Assessment and Management. Cambridge: Cambridge University Press, 2003: 19-37.
3PAICE J A. Mechanisms and management of neuropathic pain in cancer[J]. J Support Oncol, 2003, 1(2): 107-120.
4URCH C E, DICKENSON A H. Neuropathic pain in cancer [J]. Eur J Cancer, 2008, 44(8): 1091-1096.
5POLOMANO R C, FARRAR J T, Pain and neuropathy incancer survivors[J]. Cancer Nurs, 2006, 29 (2 Suppl) : 39- 47.
6ASAI H, OZAKI N, SHINODA M, et al. Heat and mechanical hyperalgesia in mice model of cancer pain[J]. Pain, 2005, 117(1-2): 19-29.
7AMAYA F, OH-HASHI K, NARUSE Y, et al. Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons[J]. Brain Res, 2003, 963 (1-2): 190-196.
8SHIMOYAMA M, TANAKA K, HASUE F, et al. A mouse model of neuropathic cancer pain[J]. Pain, 2002, 99 (1-2) : 167-174.
9SHIMOYAMA M, TATSUOKA H, OHTORI S, et al. Change of dorsal horn neurochemistry in a mouse model of neuropathic cancer pain[J]. Pain, 2005, 114(1-2): 221-230.
10PAICE J A. Mechanisms and management of neuropathie pain in caneer[J]. J Support Oncol, 2003, 1(2): 107-120.
